0.33 USD
▼-0.05-12.89%
盘后 0.34 +2.44%
2026-11-20
市值
$264.52K
市盈率
—
EPS
-12.64
股息率
—
52 周区间
0.29 – 21.75
成交量
85.89K
Beta
1.48
目标价
—
52W 低 0.2952W 高 21.75
价格走势
公司简介
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only p...